Titre : Polyribosomes

Polyribosomes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gene Expression Profiling
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Polyribosomes : Questions médicales les plus fréquentes", "headline": "Polyribosomes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Polyribosomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-06", "dateModified": "2025-05-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Polyribosomes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Ribosomes", "url": "https://questionsmedicales.fr/mesh/D012270", "about": { "@type": "MedicalCondition", "name": "Ribosomes", "code": { "@type": "MedicalCode", "code": "D012270", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.430.214.190.875.811" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Réticulum endoplasmique rugueux", "alternateName": "Endoplasmic Reticulum, Rough", "url": "https://questionsmedicales.fr/mesh/D018870", "about": { "@type": "MedicalCondition", "name": "Réticulum endoplasmique rugueux", "code": { "@type": "MedicalCode", "code": "D018870", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.284.430.214.190.875.811.740.300" } } } ], "about": { "@type": "MedicalCondition", "name": "Polyribosomes", "alternateName": "Polyribosomes", "code": { "@type": "MedicalCode", "code": "D011132", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Timur N Baymukhametov", "url": "https://questionsmedicales.fr/author/Timur%20N%20Baymukhametov", "affiliation": { "@type": "Organization", "name": "Structural biology department, National Research Center 'Kurchatov Institute', Moscow 123182, Russia." } }, { "@type": "Person", "name": "Dmitry N Lyabin", "url": "https://questionsmedicales.fr/author/Dmitry%20N%20Lyabin", "affiliation": { "@type": "Organization", "name": "Institute of Protein Research RAS, Pushchino, Moscow Region 142290, Russia." } }, { "@type": "Person", "name": "Yury M Chesnokov", "url": "https://questionsmedicales.fr/author/Yury%20M%20Chesnokov", "affiliation": { "@type": "Organization", "name": "Probe and Electron Microscopy Resource Center, National Research Center 'Kurchatov Institute', Moscow 123182, Russia." } }, { "@type": "Person", "name": "Ivan I Sorokin", "url": "https://questionsmedicales.fr/author/Ivan%20I%20Sorokin", "affiliation": { "@type": "Organization", "name": "Institute of Protein Research RAS, Pushchino, Moscow Region 142290, Russia." } }, { "@type": "Person", "name": "Evgeniya V Pechnikova", "url": "https://questionsmedicales.fr/author/Evgeniya%20V%20Pechnikova", "affiliation": { "@type": "Organization", "name": "Probe and Electron Microscopy Resource Center, National Research Center 'Kurchatov Institute', Moscow 123182, Russia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Genome-wide identification and expression profiling of sugar transporter genes in tobacco.", "datePublished": "2022-06-14", "url": "https://questionsmedicales.fr/article/35714802", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gene.2022.146652" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.", "datePublished": "2023-08-02", "url": "https://questionsmedicales.fr/article/37533202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.6411" } }, { "@type": "ScholarlyArticle", "name": "The NeuroinflammatoryPotential of HIV-1 NefVariants in Modulating the Gene Expression Profile of Astrocytes.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36291123", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cells11203256" } }, { "@type": "ScholarlyArticle", "name": "Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.", "datePublished": "2022-06-30", "url": "https://questionsmedicales.fr/article/35771282", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00401-022-02460-1" } }, { "@type": "ScholarlyArticle", "name": "Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.", "datePublished": "2024-09-24", "url": "https://questionsmedicales.fr/article/39317454", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/rmdopen-2024-004600" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Structures cellulaires", "item": "https://questionsmedicales.fr/mesh/D022082" }, { "@type": "ListItem", "position": 4, "name": "Espace intracellulaire", "item": "https://questionsmedicales.fr/mesh/D042541" }, { "@type": "ListItem", "position": 5, "name": "Cytoplasme", "item": "https://questionsmedicales.fr/mesh/D003593" }, { "@type": "ListItem", "position": 6, "name": "Structures cytoplasmiques", "item": "https://questionsmedicales.fr/mesh/D022083" }, { "@type": "ListItem", "position": 7, "name": "Organites", "item": "https://questionsmedicales.fr/mesh/D015388" }, { "@type": "ListItem", "position": 8, "name": "Ribosomes", "item": "https://questionsmedicales.fr/mesh/D012270" }, { "@type": "ListItem", "position": 9, "name": "Polyribosomes", "item": "https://questionsmedicales.fr/mesh/D011132" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Polyribosomes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Polyribosomes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Polyribosomes", "description": "Comment détecte-t-on les polyribosomes ?\nQuels tests sont utilisés pour étudier les polyribosomes ?\nLes polyribosomes sont-ils visibles en microscopie optique ?\nPeut-on quantifier les polyribosomes ?\nLes polyribosomes sont-ils liés à des maladies ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Gene+Expression+Profiling&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Polyribosomes", "description": "Quels symptômes sont liés aux dysfonctionnements des polyribosomes ?\nLes polyribosomes affectent-ils la croissance cellulaire ?\nY a-t-il des symptômes neurologiques associés ?\nLes polyribosomes influencent-ils le métabolisme ?\nPeut-on observer des symptômes immunitaires ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Gene+Expression+Profiling&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Polyribosomes", "description": "Comment prévenir les dysfonctionnements des polyribosomes ?\nLes vaccinations influencent-elles les polyribosomes ?\nY a-t-il des facteurs environnementaux à surveiller ?\nL'exercice physique a-t-il un impact ?\nDes contrôles médicaux réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Gene+Expression+Profiling&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Polyribosomes", "description": "Comment traiter les dysfonctionnements des polyribosomes ?\nDes médicaments peuvent-ils affecter les polyribosomes ?\nY a-t-il des approches nutritionnelles ?\nLes thérapies géniques peuvent-elles aider ?\nDes traitements expérimentaux existent-ils ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Gene+Expression+Profiling&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Polyribosomes", "description": "Quelles complications peuvent survenir avec des polyribosomes défectueux ?\nLes polyribosomes affectent-ils le cancer ?\nY a-t-il des risques de maladies neurodégénératives ?\nLes infections peuvent-elles aggraver les problèmes de polyribosomes ?\nDes troubles de croissance peuvent-ils survenir ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Gene+Expression+Profiling&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Polyribosomes", "description": "Quels facteurs génétiques influencent les polyribosomes ?\nL'alimentation joue-t-elle un rôle ?\nLe stress oxydatif impacte-t-il les polyribosomes ?\nLes toxines environnementales sont-elles un risque ?\nLe vieillissement affecte-t-il les polyribosomes ?", "url": "https://questionsmedicales.fr/mesh/D011132?mesh_terms=Gene+Expression+Profiling&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les polyribosomes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les polyribosomes sont généralement observés par microscopie électronique." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier les polyribosomes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse par centrifugation et l'électrophorèse sur gel sont courantes." } }, { "@type": "Question", "name": "Les polyribosomes sont-ils visibles en microscopie optique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils nécessitent une microscopie électronique pour être visualisés." } }, { "@type": "Question", "name": "Peut-on quantifier les polyribosomes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, par des méthodes comme la spectrophotométrie et l'analyse d'images." } }, { "@type": "Question", "name": "Les polyribosomes sont-ils liés à des maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans leur formation peuvent être associées à certaines pathologies." } }, { "@type": "Question", "name": "Quels symptômes sont liés aux dysfonctionnements des polyribosomes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la synthèse protéique peuvent entraîner des symptômes variés." } }, { "@type": "Question", "name": "Les polyribosomes affectent-ils la croissance cellulaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une synthèse protéique altérée peut inhiber la croissance cellulaire." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles neurologiques peuvent survenir si la synthèse protéique est affectée." } }, { "@type": "Question", "name": "Les polyribosomes influencent-ils le métabolisme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils jouent un rôle clé dans le métabolisme cellulaire par la synthèse des protéines." } }, { "@type": "Question", "name": "Peut-on observer des symptômes immunitaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans les polyribosomes peuvent affecter la réponse immunitaire." } }, { "@type": "Question", "name": "Comment prévenir les dysfonctionnements des polyribosomes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir ces dysfonctionnements." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles les polyribosomes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent améliorer la réponse immunitaire et la fonction des polyribosomes." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à surveiller ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut affecter la fonction des polyribosomes." } }, { "@type": "Question", "name": "L'exercice physique a-t-il un impact ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé cellulaire et la fonction des polyribosomes." } }, { "@type": "Question", "name": "Des contrôles médicaux réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans de santé réguliers peuvent aider à détecter des anomalies précocement." } }, { "@type": "Question", "name": "Comment traiter les dysfonctionnements des polyribosomes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause sous-jacente, souvent par des thérapies ciblées." } }, { "@type": "Question", "name": "Des médicaments peuvent-ils affecter les polyribosomes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent moduler la synthèse protéique via les polyribosomes." } }, { "@type": "Question", "name": "Y a-t-il des approches nutritionnelles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une nutrition adéquate peut soutenir la synthèse protéique et la fonction des polyribosomes." } }, { "@type": "Question", "name": "Les thérapies géniques peuvent-elles aider ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent corriger des défauts génétiques affectant les polyribosomes." } }, { "@type": "Question", "name": "Des traitements expérimentaux existent-ils ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur des traitements ciblant les polyribosomes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des polyribosomes défectueux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles métaboliques et des maladies dégénératives peuvent survenir." } }, { "@type": "Question", "name": "Les polyribosomes affectent-ils le cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans leur fonction peuvent contribuer à la progression du cancer." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies neurodégénératives ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements des polyribosomes sont liés à des maladies comme Alzheimer." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver les problèmes de polyribosomes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent perturber la synthèse protéique via les polyribosomes." } }, { "@type": "Question", "name": "Des troubles de croissance peuvent-ils survenir ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans les polyribosomes peuvent entraîner des retards de croissance." } }, { "@type": "Question", "name": "Quels facteurs génétiques influencent les polyribosomes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des mutations génétiques peuvent affecter la formation et la fonction des polyribosomes." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une carence en nutriments essentiels peut perturber la fonction des polyribosomes." } }, { "@type": "Question", "name": "Le stress oxydatif impacte-t-il les polyribosomes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut endommager les ribosomes et affecter leur fonction." } }, { "@type": "Question", "name": "Les toxines environnementales sont-elles un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines peut nuire à la synthèse protéique via les polyribosomes." } }, { "@type": "Question", "name": "Le vieillissement affecte-t-il les polyribosomes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut entraîner une diminution de l'efficacité des polyribosomes." } } ] } ] }

Sources (10000 au total)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.

Pancreatic ductal adenocarcinoma (PDAC) has the lowest survival rate of all major cancers. Chemotherapy is the mainstay systemic therapy for PDAC, and chemoresistance is a major clinical problem leadi... Archived formalin-fixed paraffin-embedded tumor tissue samples from patients treated with neoadjuvant chemotherapy were obtained during surgical resection. Specimens were macrodissected and gene expre... Initially, unsupervised multivariate modeling was performed by principal component analysis, which demonstrated a distinct gene expression profile between good- and poor-chemotherapy responders. There... A distinct tumor biological profile between PDAC patients who either respond or not respond to chemotherapy was identified....

Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

To identify differentially expressed genes in temporal artery biopsies (TABs) from patients with giant cell arteritis (GCA) with different histological patterns of inflammation: transmural inflammatio... Expression of 770 immune-related genes was profiled with the NanoString nCounter PanCancer Immune Profiling Panel on formalin-fixed paraffin-embedded TABs from 42 GCA patients with TMI, 7 GCA patients... Unsupervised clustering of the samples revealed two distinct groups: normal TABs and TABs with ILA in one group, 41/42 TABs with TMI in the other one. TABs with TMI showed 31 downregulated and 256 upr... TABs with TMI had a distinct transcriptome compared with normal TABs and TABs with ILA. The few genes potentially deregulated in ILA were also deregulated in TMI. Gene profiling allowed to deepen the ...

Identification and Validation of Common Reference Genes for Normalization of Esophageal Squamous Cell Carcinoma Gene Expression Profiles.

Esophageal squamous cell carcinoma (ESCC) is one of the subtypes of esophageal cancer with Chinese characteristics, and its five-year survival rate is less than 20%. Early diagnosis is beneficial to i...

Identification and Validation of Autophagy-Related Genes in Primary Ovarian Insufficiency by Gene Expression Profile and Bioinformatic Analysis.

To investigate the relationship between primary ovarian insufficiency and autophagy, we detected and got the expression profile of human granulosa cell line SVOG, which was with or without LPS induced... Totally, 6 genes were selected as candidate hub genes which might correlate with the process of primary ovarian insufficiency. The expression of hub genes was then validated by quantitative real-time ... The results indicated that autophagy might play an essential role in the process and underlying molecular mechanism of primary ovarian insufficiency, which was revealed for the first time and may help...

Intralesional gene expression profile of JAK-STAT signaling pathway and associated cytokines in

The JAK-STAT signaling pathway is a central cascade of signal transduction for the myriad of cytokines in which dysregulation has been implicated in progression of inflammatory and infectious diseases... This study sought to investigate differential gene expression of several cytokines and their associated... Results showed that the gene expression levelsof both Th1 (... Our finding revealed dysregulation of cytokines and related...

Identification and gene expression profiling of human gonadotrophic pituitary adenoma stem cells.

Gonadotrophic pituitary adenoma is a major subtype of pituitary adenoma in the sellar region, but it is rarely involved in the hypersecretion of hormones into blood; thus, it is commonly regarded as "... The hPASCs from 14 human gonadotrophic pituitary adenoma clinical samples were cultured and verified via immunohistochemistry. Genetic profiling of hPASCs and the matched tumor cells was performed thr... The hPASCs were successfully isolated and cultured from gonadotrophic pituitary adenoma in vitro, which were identified as positive for generic stem cell markers (Sox2, Oct4, Nestin and CD133) via imm... Genetic profiling of hPASCs may explain the tumorigenesis and invasiveness of gonadotrophic pituitary adenoma. ANXA2 may serve as a potential therapeutic target for the treatment of gonadotrophic pitu...